PolyPeptide Group Stock

PolyPeptide Group EBIT per Employee

The EBIT per Employee of PolyPeptide Group (PPGN.SW) as of Aug 12, 2026 is 6,000.57 EUR. In the previous year, EBIT per Employee was -5,960.81 EUR — a change of -200.67% (higher).

EBIT per Employee

6,000.57EUR

YoY

-200.67%

Last updated:

EBIT per Employee of PolyPeptide Group is 2026 6,000.57 EUR. EBIT per Employee of PolyPeptide Group was 2025 -5,960.81 EUR. It decreases by -200.67% higher compared to the previous year.
Access this data via the Eulerpool API

PolyPeptide Group Stock analysis

What does PolyPeptide Group do? PolyPeptide Group AG is a leading company in peptide chemistry and offers customized peptide solutions for a variety of applications to its customers. The company was founded in 1994 and is headquartered in Zurich, Switzerland. PolyPeptide has branches in seven countries and operates worldwide in over 80 countries. The company works with customers from various industries, including the pharmaceutical industry, biotechnology, diagnostics, as well as cosmetics and food industries. With many years of experience, a deep understanding of peptide chemistry, and state-of-the-art technologies, PolyPeptide is able to offer its customers first-class and tailor-made peptide solutions. PolyPeptide is divided into three divisions: Generics, Innovative Peptides, and Peptide Manufacturing. In the Generics division, the company offers a wide range of generic peptides that can be used for various applications. These peptides are manufactured to the highest quality standards and are cost-effective alternatives to expensive proprietary peptides. The Innovative Peptides division offers customized peptide solutions for specific applications. These peptides are developed in close collaboration with customers and can be used for the treatment of cancer, autoimmune diseases, diabetes, and other conditions. The third division, Peptide Manufacturing, specializes in the production of peptides for clinical studies and commercial production. PolyPeptide has modern production facilities and strict quality controls to ensure that the peptides meet the highest quality standards. PolyPeptide's business model is based on close collaboration with customers and partners to develop tailor-made peptide solutions. The company works closely with its customers to understand their requirements and develop suitable peptides for their specific applications. PolyPeptide has an experienced team of scientists and technicians specialized in peptide synthesis and continuously focuses on the latest knowledge in peptide chemistry. PolyPeptide offers a wide range of products, including generic peptides for research purposes, customized peptides for specific applications, peptides for clinical studies, and for commercial production. The company has a wealth of experience in peptide chemistry and has acquired numerous patents for its technologies and methods. In summary, PolyPeptide Group AG is a leading company in peptide chemistry. The company offers customized peptide solutions for a variety of applications and has extensive experience in manufacturing peptides for the pharmaceutical industry, biotechnology, diagnostics, cosmetics, and food industry. Through its close collaboration with customers and state-of-the-art technologies, PolyPeptide is able to offer its customers first-class and cost-effective peptide solutions, solidifying its position as a leader in peptide chemistry. PolyPeptide Group is one of the most popular companies on Eulerpool.

Frequently Asked Questions about PolyPeptide Group stock

EBIT per Employee of PolyPeptide Group is 6,000.57 EUR in 2026.

EBIT per Employee of PolyPeptide Group changed from -5,960.81 EUR to 6,000.57 EUR, representing a -200.67% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBIT per Employee PolyPeptide Group since 2006 – with annual values, charts, and detailed analysis.

EBIT per employee measures operating profit per employee, showing how efficiently the workforce generates operating earnings.

EBIT per Employee's EUR is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBIT per Employee's PolyPeptide Group historically and in real time.

Access this data via the Eulerpool API

Workforce — PolyPeptide Group

All Key Metrics — PolyPeptide Group